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Abstract
Between 1999 and 2014, the prevalence of opioid use disorder (OUD) among preg‐
nant	women	quadrupled	in	the	USA.	The	standard	treatment	for	peripartum	women	
with OUD is buprenorphine. However, the maternal behavior neurocircuit that regu‐
lates maternal behavior and mother‐infant bonding has not been previously stud‐
ied for human mothers receiving buprenorphine treatment for OUD (BT). Rodent 
research shows opioid effects on reciprocal inhibition between maternal care and 
defence maternal brain subsystems: the hypothalamus and periaqueductal gray, 
respectively. We conducted a longitudinal functional magnetic resonance imaging 
(fMRI) pilot study in humans to specifically examine resting‐state functional con‐
nectivity (rs‐FC) between the periaqueductal gray and hypothalamus, as well as to 
explore associations with maternal bonding for BT. We studied 32 mothers who com‐
pleted fMRI scans at 1 month (T1) and 4 months postpartum (T2), including seven 
mothers receiving buprenorphine for OUD and 25 non‐OUD mothers as a compari‐
son group (CG). The participants underwent a 6‐minute resting‐state fMRI scan at 
each time point. We measured potential bonding impairments using the Postpartum 
Bonding Questionnaire to explore how rs‐FC with periaqueductal gray is associ‐
ated with bonding impairments. Compared to CG, BT mothers differed in periaq‐
ueductal gray‐dependent rs‐FC with the hypothalamus, amygdala, insular cortex 
and other brain regions at T1, with many of these differences disappearing at T2, 
suggesting potential therapeutic effects of continuing buprenorphine treatment. In 
contrast, the “rejection and pathological anger” subscale of the Postpartum Bonding 
Questionnaire at T1 and T2 was associated with the T1‐to‐T2 increases in periaq‐
ueductal gray‐dependent rs‐FC with the hypothalamus and amygdala. Preliminary 
evidence links maternal bonding problems for mothers with OUD early in the post‐
partum to connectivity between specific care and defence maternal brain circuits, 
which may be mitigated by buprenorphine treatment. This exploratory study sup‐
ports a potential mechanism for investigating both the therapeutic benefits and risks 
of opioids for maternal care and bonding with infants.
K E Y W O R D S
bonding, buprenorphine, hypothalamus, maternal brain behaviour neurocircuit, mothers, 
neuroimaging, opioid, periaqueductal gray, resting‐state functional connectivity
2 of 16  |     SWAIN ANd HO
1  | INTRODUC TION
The	opioid	epidemic	 in	 the	USA	directly	affects	millions	of	women,	
with approximately 20% of all pregnant women being prescribed opi‐
oids and 2.5% chronically using opioids,1 and the number of pregnant 
women with opioid use disorder (OUD) having more than quadrupled 
from 1999 to 2014 (from 1.5 per 1,000 delivery hospitalisations to 
6.5).2 The standard of care for OUD among pregnant women is opioid 
maintenance therapy with buprenorphine. Buprenorphine treatment 
for OUD (BT)3‐6 is a common choice of treatment to mitigate the phys‐
iological stress associated with repeated cycles of maternal/foetal in‐
toxication and withdrawal, preserving uterine stability via receptor 
occupancy.7‐9 Compared to detoxification10,11 and possibly metha‐
done treatment,12‐20 BT may result in milder neonatal abstinence syn‐
drome.6,21‐28 However, the effects of buprenorphine treatment (BT) 
on the human maternal brain affected by OUD are not well under‐
stood.29 So far, there is just one study of mothers with polysubstance 
addictions showing reduced activation in reward regions of the brain 
in response to their own infant's face cues30; and one of mothers with 
BT for OUD vs depressed controls showing increased own vs other 
baby cry responses in multiple motivation brain regions.31
Maternal substance use in general places their infants at a four‐
fold increased risk for abuse or neglect, contributing to as much as 
80% of child maltreatment cases32 and 60% of infant out‐of‐home 
placements.33 Opioid‐induced deficits in homologous maternal be‐
haviours have also been established in animal models.34‐36 These 
effects appear to be mediated in part by activation of mu‐opioid re‐
ceptors	in	the	hypothalamic	medial	preoptic	area	(mPOA).37‐39 More 




ing behaviours to defensive/aggressive behaviours such as preda‐
tion in rodents40 that are known to be regulated by mu and kappa 
opioid receptor activity.41,42 Indeed, infusion of a mu‐opioid receptor 
agonist	into	the	ventrolateral	PAG	disrupts	the	balance	of	maternal	
care and aggression and kappa‐opioid receptor antagonism, shift‐
ing behaviours from maternal caring to predation behaviours in ro‐
dents.41 These recent results are particularly relevant for mothers 
receiving buprenorphine for OUD (BT) because buprenorphine is 
both a partial mu‐opioid receptor agonist and kappa‐opioid recep‐
tor	antagonist.	The	hypothalamus	and	PAG	are	key	parts	of	a	ma‐
ternal behaviour neurocircuit (MBN) (Figure 1) that is necessary for 
the survival of mammals from well‐developed rodent models.43‐49 In 
this scheme, maternal caregiving and defensive/aggressive systems 
are	balanced	with	reciprocal	 inhibition	of	 the	hypothalamic	mPOA	
and	PAG	respectively.50 Thus, mothers would not be distracted from 
sensitive maternal care in the absence of threat or exhibit insensitive 
or aggressive behaviour toward their infant.
We postulate that human mothers have a homologous MBN 
(Figure 1),51‐53 including opposing maternal “care” and “defence” 
subsystems, that reciprocally inhibit each other to balance maternal 
sensitive infant care behaviours with need for defensive/aggressive 
behaviours that maintain safety.31 The care subsystem includes the 
mPOA	in	hypothalamus,	ventral	tegmental	area,	nucleus	accumbens	
and ventral pallidum that regulate maternal caregiving behaviours 
such as licking and grooming for rodents, as well as sensitive, at‐
tuned care, gentle gaze, voice, touch and movement for humans.54 
In	the	defence	subsystem,	the	PAG	may	activate	maternal	defensive	
behaviours, such as aggression toward intruders and predatory be‐
haviours.	Among	humans,	PAG	has	been	activated	a	baby	distress	
cry,55 with such activity being related to mental state talk.56 This 
is interesting because a mother would need to balance caring and 
defensive behaviours in response to a cry which may solicit care 
or signal emergent concerns for safety.57 The regulation of other 
regions of the two subsystems of the MBN to orchestrate parent‐
ing has been demonstrated with human functional magnetic reso‐
nance imaging (fMRI) studies, including for the amygdala,58‐60 insular 
cortex,61,62 orbitofrontal cortex (OFC)63 and hypothalamus64‐66 
in response to infant cues. These regions may also be affected by 




to ethologically pertinent own‐baby cry correlate with adaptive parental thoughts and behaviors


















     |  3 of 16SWAIN ANd HO
addiction and polysubstance use,30,31,67,68 suggesting the need for 
more research on task‐based brain physiology in the maternal brain. 
There is growing recognition, however, that high‐order cognitive and 
emotional function, such as required for human parenting, may de‐
pend on coherent activity between key brain regions within neuro‐
circuits, rather than single regions.
Resting‐state functional connectivity (rs‐FC) is a method that 
is used in fMRI to examine regional interactions during a resting or 
task‐negative state, during which time an explicit task is not being 
performed.69,70 Resting brain state conditions are observed through 
changes in blood‐oxygen‐level‐dependent (BOLD) signals. Despite 
limitations of low temporal resolution and regional variation in neu‐
rovascular physiology, the resting state approach is useful to explore 
the brain's functional organisation in terms of apparent functional 
connectivity71 It has revealed networks of synchronous activity that 
are consistently found in healthy subjects, as well as in different 
stages of consciousness, in mental disorders and across species.72,73 
As	in	the	present	study,	rs‐FC	may	be	particularly	to	pursue	a	priori	
hypotheses in established circuits.74
So far, there are just one rodent and two human maternal brain 
studies using resting‐state connectivity methods described above. 
Rat dams with early‐life chronic social stress showed depressed 
maternal care specifically during early lactation, and changes in 
functional connectivity in regions associated with sensory pro‐
cessing, maternal and emotional responsiveness, memory and the 
reward	 pathway,	 including	 reduced	 PAG‐anterior	 cingulate	 con‐
nectivity.75	Among	human	mothers,	eight	with	depression	vs	nine	
healthy at 9 weeks postpartum, there was decreased functional 
connectivity in numerous corticolimbic circuits, such as coupling 
within the default mode network (DMN), including anterior cingu‐
late	 cortex	 (ACC),	 inferior	parietal	 cortex	 and	precuneus,	 as	well	
as between DMN nodes and amygdala.76 In another human study 
performed at 10 weeks postpartum, 14 depressed vs 23 healthy 
mothers showed decreased DMN activity using a PCC seed re‐
gion.77 These results may be interpreted to reflect diminished self‐
reflection and social cognition,78 as well as thoughts about duties 
and responsibilities to others,79 which are important to parenting. 
Additional	 research	 related	 to	 the	 content	 of	maternal	 thoughts	
during the resting phase may be important to clarify the relation‐
ship between maternal thoughts moods and caregiving in health 
and mental illness.80
In the present study, we hypothesise that the specific func‐
tional	connectivity	between	the	hypothalamus	and	PAG,	which	are	
two functionally opposing regions in MBN,50 may be decreased in 
mothers receiving buprenorphine for OUD and relate to impaired 
bonding, consistent with rodent deficits in maternal behaviour with 
opioids.34,35	We	thus	examined	rs‐FC	between	the	PAG	and	hypo‐
thalamus in BT mothers with reference to a comparison group (CG) of 
mothers who did not have OUD or receive any psychotrophic medi‐
cation. Furthermore, to examine the roles of functional connectivity 
between	PAG	and	hypothalamus	in	possible	dysregulation	of	mater‐
nal	behaviours,	we	also	explored	how	the	PAG‐dependent	rs‐FC	may	
be related to symptoms of mother‐infant bonding impairments, as 
measured by the Postpartum Bonding Questionnaire (PBQ),81 in BT 
and CG mothers in the early postpartum period. The PBQ was cho‐
sen for this purpose because its subscales of Impaired Bonding (IB), 
Rejection	and	Pathological	Anger	(RPA)	and	Infant‐Focused	Anxiety	
(IFA)	have	been	linked	to	maternal	psychological	abuse	of	infants	and	
maternal depression in multiple cultures.82‐85 We know that depres‐
sion is common comorbidity of OUD 86,87 and that depressive symp‐
toms, even if not meeting the clinical threshold,88‐90 can seriously 
risk adverse child outcomes across cognitive, behavioural and social 
domains.91‐96
2  | MATERIAL S AND METHODS
2.1 | Procedures
Participants were recruited from community health clinics, primary 
care clinics, and the University of Michigan Medicine Centers. They 
received an initial screening in the third trimester of pregnancy and 
completed questionnaires before undergoing two fMRI scanning 
sessions, at 1 month postpartum (T1) and 4 months postpartum 
(T2). Participants with OUD were prescribed BT as part of routine 
medical care and there were no infant admissions for medical com‐
plications	after	initial	neonatal	abstinence	syndrome.	All	procedures	
were approved by the Human Subject Institutional Review Board at 
University of Michigan.
2.2 | Participants
For the sample in the present study (n = 32), we included group 
of mothers who were maintained on buprenorphine replace‐
ment therapy for their OUD (BT) (n = 7, years of age; mean ± SD 
29.86 ± 6.62 years) and a comparison group (CG) of mothers who re‐
ported no opioid or other substance uses or any psychotrophic med‐
ications (CG, n = 25, years of age; mean ± SD 27.62 ± 8.46 years). 
Mean ± SD ages for infants of early postpartum mothers were 
0.08 ± 0.01 years for BT and 0.07 ± 0.27 years for CG. The BT 
mothers received buprenorphine medication during pregnancy and 
continued throughout the time of the study. The mean ± SD dose 
recorded every 2 weeks postpartum was 14.18 ± 3.35 mg, with six 
out of seven mothers stabilising between 12 and 16 mg.
2.3 | Self‐reported measure
2.3.1 | Postpartum bonding questionnaire
The PBQ is a 25‐item self‐report questionnaire developed to screen 
early postpartum women for potential parent‐infant bonding dis‐
orders.97 The PBQ consists of four subscales to indicate factors of 
clinical relevance, namely IB (subscale 1 with sensitivity of 0.82 for 
detecting mothers with bonding disorders) (e.g. “I feel distant from 
my	 baby”);	 RPA	 (subscale	 2	with	 sensitivity	 of	 0.88	 for	 infant	 re‐
jection and 0.67 for severe anger), identifies mothers with serious 
infant‐oriented	hostility	 (e.g.	 “I	 resent	my	baby”);	 IFA	 (subscale	3),	
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which may be useful in anxious mothers (e.g. “My baby makes me 
feel anxious”); and subscale 4, which signals the presence of incipi‐
ent abuse that would require urgent intervention (e.g. “I have done 
harmful things to my baby”). None of the participants indicated 
abuse	from	subscale	4	and	only	the	first	three	subscales	(IB,	RPA	and	
IFA)	were	examined	in	the	current	study.
2.4 | Functional and structural magnetic 
resonance imaging
2.4.1 | Imaging data acquisition
During the fMRI scanning session, each participant was positioned 
in	a	supine	orientation	with	her	head	positioned	in	a	head	coil.	Visual	
stimuli (a cross at the centre) were presented via a goggle system and 
NordicNeuroLab (Bergen, Norway) audio system. The fMRI scanning 
was performed with a 3.0 Tesla Philips magnetic resonance imag‐
ing	scanner	(Philips,	Eindhoven,	The	Netherlands)	using	a	standard	
eight‐channel	 radiofrequency	SENSE	head	 coil. with the following 
acquisitions: (i) a high‐resolution T1 scan was acquired to provide 
precise	anatomical	localisation	(TR	of	9.8	ms,	TE	=	459	ms,	FA	=	8°,	
FOV	of	256	mm,	slice	thickness	of	1.0	mm,	180	slices	with	288	×	288	
matrix	per	 slice)	 and	 (ii)	A	 run	of	T2*‐weighted	BOLD	echo	planar	
imaging sequence volumes was acquired for whole‐brain fMRI dur‐
ing	the	resting‐state	task	(180	frames,	TR	=	2000	ms,	TE	=	30	ms,	
FA	 =	 90°,	 FOV	 =	 220	mm,	 42	 contiguous	 axial	 slices,	 slice	 thick‐
ness	=	2.8	mm	with	64	×	64	matrix	per	slice,	voxel	size	=	3.44	×	3.44	
×	2.8	mm3), after discarding the first five initial frames to allow for 
equilibration of scanner signal.
2.4.2 | Imaging data processing and analysis
Functional MRI data were pre‐processed and analysed using statis‐
tical parametric mapping software (spm8; Welcome Department of 
Imaging Neuroscience, London, UK). Slice timing correction was per‐
formed using a middle slice as a reference (slice 21).98	After	slice	time	
correction, images within each run were realigned to the mean image 
of the first run to correct for movement. Realigned functional images 
and	 structural	 images	were	 spatially	 normalised	 using	 the	DARTEL	
method in spm8.99 The normalised functional images were re‐sliced 
to	2	×	2×2	mm	voxels.	Images	were	then	spatially	smoothed	using	a	
Gaussian filter with a full‐width half‐maximum value of 8 mm. To as‐
sess and mitigate movement artifact, we calculated the frame‐wise 
displacement (FD), defined as the sum (in millimetres) of the abso‐
lute values of frame displacement in successive functional volumes, 
based on six translation and rotation parameters from the realignment 
file.100 Rotational displacements were converted from degrees to mil‐
limeters	moved	on	the	surface	of	a	50‐mm	sphere.	A	frame‐scrubbing	
routine was used to censor out any frame with FD > 0.5 mm from 
the regression analysis described below, yielding a scrub ratio for 
each subject, with a cut‐off of 60% censored‐out frames for sample 
exclusion, in accordance with the literature showing that as many as 
60% of frames can be removed and still yield analysable results.100,101 
There was no BT vs CG difference in the averaged FD before scrub‐
bing (BT: mean ± SD: 0.379 ± 0.063; CG: mean ± SD: 0.300 ± 0.028; 
F1,40 = 1.284, MSerror = 0.056, P = .264). This suggests no significant 
head movement as a potential confounding factor between groups. 
Three‐compartment segmentation of the high‐resolution structural 
image	 from	 the	 DARTEL	 normalisation	 were	 applied	 to	 the	 func‐
tional time series to extract cerebral spinal volume and white matter 
compartments, which then were subjected to a principal component 
analysis to identify the top five components in each,102 which should 
correspond to heart rate and respiratory effects on the BOLD sig‐
nal.103	Adjusted	 time	courses	were	derived	 from	sequential	 regres‐
sions of the time series with the following regressors: linear trend of 
six motion parameters, their temporal derivatives, the quadratics of 
these 12 parameters, five components from the principal components 
analysis of cerebral spinal volume, five components of white matter, 
followed by band‐pass filtering from 0.01 to 0.1 Hz, and then motion 
scrubbing.	The	seed	mask	of	PAG,	as	a	region	of	interest	(ROI),	in	rs‐
fMRI analysis was generated using pickatlas	software	(WFU	PickAtlas;	
http://fmri.wfubmc.edu/softw are/picka tlas) as a box‐shaped mask 
centered	at	the	ventrolateral	PAG	(MNI:	x = 0, y	=	−27,	z	=	−8,	with	
3	×	1	×	1	mm	extensions),	in	accordance	with	the	literature.104,105 In 
the first‐level analysis, adjusted time courses were averaged across 
all voxels in the seed mask. The average time course in the seed was 
correlated with time courses from all other voxels in the brain, Fisher 
r‐to‐Z transformed, and taken to second level, between‐group analy‐
ses. In the second‐level analysis, statistical parametric maps in the 
first model were submitted to general linear models (GLMs) to test for 
the effects of interest. The effects of interest included the group dif‐
ference (BT vs Controls) in the sample of 32 mothers and each of the 
three PBQ subscales in a subsample of BT and CG mothers (n = 5 in 
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each	group).	All	of	the	second‐level	models	were	controlled	for	whole‐
brain multiple comparisons at the cluster level for voxel‐wise intensity 
threshold at P < .001, which is considered to yield reliable statisti‐
cal inference.106	We	also	used	Threshold‐Free	Cluster	Enhancement	
(TFCE)	method	 107 to perform family‐wise small volume correction 
(s.v.c.) in a ROI mask of the hypothalamus (MNI: x =±4, y	=	−2,	z	=	−12,	
with	 a	 4‐mm	 radius)	 to	 examine	 the	 PAG‐hypothalamus	 functional	
connectivity in accordance with the hypothesis that the reciprocal in‐
hibition	between	PAG	and	hypothalamus	plays	a	key	role	with	respect	
to regulating maternal behaviours.
2.5 | Behavioural data analysis
We	 investigated	 the	 associations	between	 the	PAG‐hypothalamus	
functional	 connectivity	 and	 three	 subscales	 of	 PBQ	 (IB,	 RPA	 and	
IFA)	 at	 T1	 and	 T2	 in	 the	 early	 postpartum	mothers,	 using	 bivari‐




The participants in BT and CG did not differ with respect to 
their age (F1,30 = 0.081, MSerror = 70.25, P = .78), number of off‐
spring (F1,30 = 0.16, MSerror = 0.45, P = .69) and youngest child's 
age in the early postpartum mothers (F1,8 = 1.00, MSerror = 0.01, 
P = .35). For demographics, see Table 1. In a mixed model of GLM, 
we investigated the main effects of group (BT vs CG), Time (T1 
and T2) and Time by Group interaction effect in three subscales 
F I G U R E  2  The	group	by	timeline	charts	for	three	subscales	of	postpartum	bonding	questionnaire	(PBQ).	A,	The	impaired	bonding	
subscale	(IB).	B,	The	rejection	and	pathological	anger	subscale	(RPA).	C,	The	infant‐focused	anxiety	subscale	(IFA).	Abbreviations:	BT,	
buprenorphine treatment for opioid use disorder; CG, comparison group. T1, 1 month postpartum; T2, 4 months postpartum 
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of voxels Z scorex y z
BT > CG
Inferior temporal gyrus R 68 −28 −24 119 5.21
Septal area/caudate nucleus R/L −4 16 4 478 5.05
Amygdala/hippocampus R 24 −14 −12 220 4.88
Hypothalamusa R/L 4 −2 −12 44 2.42
BT < CG
Supramarginal gyrus R 58 −46 30 1111 5.55
Middle temporal gyrus L −46 −58 8 487 5.14
Posterior cingulate cortex/
precuneus
R 14 −46 12 655 4.94
Postcentral gyrus L −68 −14 26 108 4.61
Middle cingulate cortex R 18 −36 40 298 4.59
Insular cortex R 48 6 −2 122 4.57
Precentral gyrus R 48 −2 50 86 4.51
Precuneus, dorsal R/L −6 −56 60 160 4.49
Abbreviations:	BT,	buprenorphine	treatment	for	opioid	use	disorder;	CG,	comparison	group;	PAG,	
periaqueductal gray; rs‐FC, resting‐state functional connectivity.
aExcept	this	a	priori	region	of	interest,	all	regions	listed	above	were	cluster‐level	whole‐brain	cor‐
rected (family‐wise error correction < .05) at voxel‐wise P = .001. 
TA B L E  2   BT vs CG main effects on 
PAG‐dependent	rs‐FC	at	T1
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of PBQ. We found that there were no significant group main ef‐
fects for any of the PBQ subscales (IB: F1,6 = 0.002, MSerror = 35.90, 
P = .97;	RFA:	F1,6 = 0.026, MSerror = 9.63, P = .88;	 IFA:	F1,6 = 1.49, 
MSerror = 5.06, P = .27); there was a significant main effect of Time 
in	IFA	(F1,6 = 21.00, MSerror = 0.15, P = .004), although not the other 
subscales (IB: F1,6 = 2.45, MSerror = 15.98, P = .17;	RPA:	F1,6 = 3.10, 
MSerror = 3.96, P = .13); there were no significant Time by Group 
interaction effects for any of the subscales, although there was a 
marginal	trend	for	IFA	(IB:	F1,6 = 0.066, MSerror = 15.98, P = .45;	RFA:	
F1,6 = 0.001, MSerror = 3.96, P = 1.00;	IFA:	F1,6 = 3.86, MSerror = 0.15, 
P = .10). For the Time by Group line charts of PBQ subscales, see 
Figure 2.
F I G U R E  3  The	group	main	effects	on	the	periaqueductal	gray	(PAG)‐dependent	resting‐state	functional	connectivity	(rs‐FC)	at	1	month	
postpartum. The red/warm coloured clusters indicate buprenorphine treatment for opioid use disorder (BT) > comparison group (CG) 
differences and the blue/winter colored clusters indicate CG > BT differences; all clusters shown are whole‐brain corrected at the cluster 
level,	except	the	a	prior	region	of	interest,	hypothalamus*.	Abbreviations:	AMY/HIP,	amygdala/hippocampus;	dPrC,	dorsal	precuneus;	
IC, insular cortex; ITG, inferior temporal gyrus; MTG, middle temporal gyrus; PCC/Prc, posterior cingulate cortex/precuneus; PosCG, 
postcentral	gyrus;	PreCG,	precentral	gyrus;	SA/CN,	septal	area/caudate	nucleus;	SMG,	supramarginal	gyrus.	The	z‐	or	y‐coordinates	of	the	
slices are listed below the images, which are rendered in neurological convention (the right side of image is the right hemisphere)
T1 Group main effects on rs-FC w/PAG
PreCG
PosCG










z = –12 z = –2 z = 10z = –26
Brain region Side
MNI coordinates
Number of voxels Z scorex y z
BT > CG




R/L 2 32 2 198 4.48
Anterior	cingulate	
cortex, ventral
L −12 42 −10 89 3.82
Abbreviations:	BT,	buprenorphine	treatment	for	opioid	use	disorder;	CG,	comparison	group;	PAG,	
periaqueductal gray; rs‐FC, resting‐state functional connectivity.
aExcept	this	a	priori	region	of	interest,	all	regions	listed	above	were	cluster‐level	whole‐brain	cor‐
rected (family‐wise error correction < .05) at voxel‐wise P = .001. 
TA B L E  3   BT vs CG main effects on 
PAG‐dependent	rs‐FC	at	T2
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3.2 | Neuroimaging results
3.2.1 | Main effects of group at T1 and T2, time, and 
time by group interactions
We examined the main effects of Group at timepoint, the main ef‐
fects	of	Time	and	the	Time	by	Group	interaction	effects	on	the	PAG‐






poral gyrus, dorsal caudate nucleus/septal area and right amygdala/
hippocampus	complex;	when	examining	a	prior	ROI	using	TFCE,	we	
also	 found	 that	 the	 PAG‐dependent	 rs‐FC	with	 the	 hypothalamus	
was	stronger	in	BT	compared	to	CG	mothers	at	T1(MNI:	[4,	−4,	−10],	
25	voxels,	TFCE = 27.00, P = .026 s.v.c.). Conversely, BT vs CG moth‐
ers	showed	a	less	PAG‐dependent	rs‐FC	in	the	right	supramarginal	
gyrus, bilateral middle temporal gyrus (MTG), precuneus/posterior 




showed	 PAG‐dependent	 rs‐FC	 that	was	 greater	 than	 those	 in	 CG	
mothers	 in	 the	 hypothalamus	 ROI	 (MNI:	 [−6,	 −4,	 −10],	 three	 vox‐
els,	TFCE = 19.61, P = .041 s.v.c.). Conversely, BT mothers showed 
a	 less	PAG‐dependent	 rs‐FC	 in	 the	dorsal	 and	ventral	ACC	 (dACC	
and	vACC).
For the Time by Group interaction effects, the results are sum‐
marised in Table 4 and Figure 5. We found that, compared to CG 
mothers,	BT	mothers	showed	greater	T1‐to‐T2	increases	of	the	PAG‐
dependent rs‐FC with the right MTG and insular cortex; conversely, 
there	were	greater	T1‐to‐T2	decreases	in	the	PAG‐dependent	rs‐FC	
with	the	dorsal	precuneus,	left	OFC,	septal	area	and	dACC.
3.2.2 | PBQ associations with PAG‐dependent rs‐FC
We explored the associations between three subscales of PBQ 
(IB,	RPA	and	IFA)	and	the	PAG‐dependent	rs‐FC	with	the	brain	re‐
gions reported in the results above in the early postpartum moth‐
ers, namely the hypothalamus, right amygdala/hippocampus, right 
MTG,	 right	 insular	 cortex,	 septal	 area/caudate	nucleus,	dACC,	 left	
OFC and dorsal precuneus (for the line charts of the parameter esti‐
mates	of	these	regions	by	group	and	time,	see	Figure	6).	Among	the	
regions reported above, only the hypothalamus and right amygdala 
PAG‐dependent	rs‐FC	were	associated	with	some	of	the	subscales	
in PBQ, as described below. The BT and CG mothers did not differ 
with respect to the associations between any of the PBQ subscales 
and	PAG‐dependent	rs‐FC.
Across	 both	 groups,	 the	 T1‐to‐T2	 changes	 in	 the	 PAG‐depen‐
dent rs‐FC with the hypothalamus were associated with T1 PBQ IB 
(r = .70, P = .025)	and	RPA	 (r = .76, P = .011),	but	not	 IFA	 (r = .31, 
P = .38),	and	with	T2	PBQ	RPA	(r = .81, P = .014), but not IB (r = .46, 
P = .25)	and	IFA	(r = −.097,	P = .82) (Figure 7). The T1‐to‐T2 changes in 
the	PAG‐dependent	rs‐FC	with	the	right	amygdala	were	associated	
with	T1	PBQ	RPA	(r = .72, P = .019)	and	IFA	(r = .65, P = .043), but not 
F I G U R E  4   The group main effects on 
the	periaqueductal	gray	(PAG)‐dependent	
resting‐state functional connectivity 
(rs‐FC) at 4 months postpartum. The 
blue/winter colored clusters indicate 
comparison group (CG) > buprenorphine 
treatment for opioid use disorder (BT) 
differences, all clusters shown are 
whole‐brain corrected at the cluster level. 
Abbreviations:	dACC,	dorsal	anterior	
cingulate	cortex;	vACC,	ventral	anterior	
cingulate cortex. The z‐coordinates of the 
slices are listed below the images, which 
are rendered in neurological convention 
(the right side of image is the right 
hemisphere)
T2 Group main effects on rs-FC w/PAG
z = 22 z = 34 z = 46 z = 58
z = 26 z = –10 z = –2 z = 10
dACC
vACC
8 of 16  |     SWAIN ANd HO
IB (r = .48, P = .17), and with T2 PBQ IB (r = .82, P = .013)	and	RPA	
(r = .73, P = .039),	but	not	IFA	(r = .41, P = .32) (Figure 8).
4  | DISCUSSION
In	the	context	of	an	unprecedented	opioid	crisis	in	the	USA,	many	
peripartum women with OUD are treated with buprenorphine 
maintenance treatment,3 despite concerns for parenting among 
affected human mothers.29 Rodent research indicates that opioids 
can	disrupt	maternal	 behaviour	 by	 acting	 on	 the	PAG	and	other	
maternal brain circuit regions including the hypothalamus.34‐36 We 
investigated whether a group of women with OUD and buprenor‐
phine treatment (BT mothers) differed from a comparison group 
(CG) of non‐OUD mothers during the early postpartum with re‐
spect to the resting‐state functional connectivity associated with 
the	 PAG	 (PAG‐dependent	 rs‐FC)	 in	 the	maternal	 brain	 neurocir‐
cuit.48,49 We found that, at 1 month postpartum (T1), compared 
to	CG,	BT	mothers	 showed	greater	PAG‐dependent	 rs‐FC	 in	 the	
right inferior temporal gyrus, septal area/caudate nucleus, right 
Brain region Side
MNI coordinates
Number of voxels Z scorex y z
BT > CG in T1‐to‐T2 increases
Middle temporal 
gyrus
R 60 −40 4 211 4.78
Insular cortex R 48 10 −6 110 4.51
BT > CG in T1‐to‐T2 decreases
Precuneus, dorsal L −26 −74 50 137 5.03
Orbital frontal 
cortex
L −18 32 −18 169 4.84
Septal area/cau‐
date nucleus
R/L −10 0 6 271 4.78
Anterior	cingulate	
cortex, dorsal
L −2 30 10 175 4.58
Note:	All	regions	listed	above	were	cluster‐level	whole‐brain	corrected	(family‐wise	error	correc‐
tion < .05) at voxel‐wise P = .001.
Abbreviations:	BT,	buprenorphine	treatment	for	opioid	use	disorder;	CG,	comparison	group;	PAG,	
periaqueductal gray; rs‐FC, resting‐state functional connectivity.
TA B L E  4   Group (BT vs CG) by Time 
interaction	effects	on	PAG‐dependent	
rs‐FC
F I G U R E  5   The group by time 
interaction effects on the periaqueductal 
gray	(PAG)‐dependent	resting‐state	
functional connectivity (rs‐FC). The 
red/warm colored clusters indicate 
buprenorphine treatment for opioid use 
disorder (BT) > comparison group (CG) 
in 1 month postpartum (T1) to 4 months 
postpartum (T2) increases and the blue/
winter colored clusters indicate BT > CG 
in T1‐to‐T2 decreases, all clusters shown 
are whole‐brain corrected at the cluster 
level.	Abbreviations:	dACC,	dorsal	anterior	
cingulate cortex; IC, insular cortex; MTG, 
middle	temporal	gyrus;	SA/CN,	septal	
area/caudate nucleus; OFC, orbital frontal 
cortex. The z‐coordinates of the slices 
are listed below the images, which are 
rendered in neurological convention (the 
right side of image is the right hemisphere)
Time × Group effects on rs-FC w/PAG






z = –26 z = –14 z = –2 z = 10
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amygdala/hippocampus and hypothalamus; they also showed a 
less	PAG‐dependent	 rs‐FC	 in	 the	 supramarginal	 gyrus,	 posterior	
cingulate cortex/precuneus, postcentral gyrus, middle cingulate 
cortex,	 insular	cortex,	precentral	gyrus	and	dorsal	precuneus.	At	
4 months postpartum (T2), compared to CG, BT mothers showed a 
marginally	greater	PAG‐dependent	rs‐FC	in	the	hypothalamus	and	
a	significantly	less	PAG‐dependent	rs‐FC	in	the	ventral	and	dorsal	
anterior cingulate cortex. In terms of Time by Group interaction, 
BT mothers, compared to CG, showed greater T1‐to‐T2 increases 
in	 the	 PAG‐dependent	 rs‐FC	 in	 the	 right	middle	 temporal	 gyrus	
and insular cortex as a result of a reversal of the initial negative rs‐
FC	with	PAG	in	these	regions;	they	also	showed	greater	T1‐to‐T2	
decreases	in	the	PAG‐dependent	rs‐FC	in	the	septal	area/caudate	
nucleus, dorsal anterior cingulate cortex, left orbital frontal cortex 
and dorsal precuneus as a result of a reversal of the initial positive 
rs‐FC	with	PAG	in	these	regions.
We	 also	 explored	 whether	 the	 PAG‐dependent	 rs‐FC	 in	 any	
of the brain regions, showing group differences, was associated 
with deficits in maternal behaviours, as measured by the PBQ. 
Although	 the	 BT	 and	 CG	mothers	 did	 not	 differ	 with	 respect	 to	
the	subscales	of	PBQ,	such	as	for	IB,	RPA	and	IFA,	we	found	that	
the	T1‐to‐T2	changes	 in	PAG‐dependent	rs‐FC	with	the	hypothal‐
amus and right amygdala were positively correlated with some of 
the subscales of PBQ at T1 and T2. By contrast to group difference 
F I G U R E  6   The group by timeline 
charts for brain regions showing group 
differences in their resting‐state 
functional connectivity (rs‐FC) with the 
periaqueductal	gray	(PAG),	as	indicated	
in	Figures	3‐5.	A,	Hypothalamus.	B,	Right	
amygdala/hippocampus. C, Right middle 
temporal gyrus. D, Right insular cortex. 
E,	Septal	area/caudate	nucleus.	F,	Dorsal	
anterior cingulate cortex. G, Left orbital 
frontal cortex. H, Dorsal precuneus. 
Abbreviations:	BT,	buprenorphine	
treatment for opioid use disorder; 
CG, comparison group. T1, 1 month 
postpartum; T2, 4 months postpartum
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analysis, correlation analysis may have detected a difference be‐











extent.	 Because	 RPA	 reflect	 outward	 expression	 of	maternal	 ag‐
gression towards the infants, we have found preliminary evidence 
for	 the	 roles	 of	 the	 PAG‐hypothalamus	 and	 PAG‐amygdala	 rs‐FC	
in the dysregulation of maternal aggression, which may reflect 
an	 impairment	 in	 the	 reciprocal	 inhibition	 between	 PAG	 and	 the	
hypothalamus and their roles in maternal aggression and caregiving 
behaviours, respectively.
Among	human	mothers,	PAG	regional	responses	have	been	re‐
lated to observing pictures of a mother's own child vs an unknown 
child.108,109 These task‐based studies have not analysed the recip‐
rocal	inhibition	between	PAG	and	maternal	care	regions	such	as	the	
hypothalamus.	It	is	possible	that	PAG	activation	in	these	studies	was	
part of a balanced response to own infant cues, in which mothers 
may have been preparing to exhibit caring or defensive behaviours 
depending on other circumstances. In support, in a recent study of 
mothers,110	PAG	connectivity	with	OFC	during	own	vs	other	baby	
picture task was inversely related to parenting stress. Perhaps, in 
that study,110 stress reduces OFC regulation of defensive and ag‐
gressive	drives	from	the	PAG,	in	accordance	with	circumstances	in	
which a stressed mother must prepare to defend their infant. Future 
studies may be able to assess the timing of regional brain activity, 
aiming to describe the order by which brain regions influence each 
F I G U R E  7   The scatter plots relating 
the 1 month postpartum (T1) to 
4 months postpartum (T2) changes in the 
periaqueductal	gray	(PAG)‐hypothalamus	
resting‐state functional connectivity 
(rs‐FC) to T1/T2 Postpartum Bonding 




BT, buprenorphine treatment for opioid 
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other. In the only rs‐FC rodent study of the homologous maternal 
brain,	connectivity	between	PAG	and	ACC	was	decreased	for	dams	
with early‐life chronic social stress and interpreted as a decrease the 
reward salience of pups, resulting in depressed maternal care during 
early lactation. There was also an improvement in connectivity from 
early to late lactation (similar levels between groups during late lac‐
tation), which is considered to be the result of cumulative exposure 
to pup‐related stimuli, such as that observed when nulliparous rats 
are induced to express maternal care by exposure to foster pups.111 
Below, we discuss the possible maternal brain roles for regions that 
we	 report	 to	 have	PAG‐dependent	 rs‐FC	 differences	 between	BT	
and CG at T1 and T2.
Connectivity	of	PAG	with	other	regions	of	the	care	and	defence	
subsystems of the MBN to orchestrate parenting in humans is con‐
sistent with task‐based fMRI responses to infant stimuli in the amyg‐
dala,58‐60 insular cortex,61,62 OFC63 and hypothalamus.64‐66 In rodent 
studies,	 oxytocin	 neurones	 in	 the	 in	 mPOA	 of	 the	 hypothalamus	
regulate dopamine function in the ventral tegmental area and me‐
diate the reward salience of pups.112,113 In another rat model, dis‐
rupted	hypothalamus	connectivity	with	PAG	was	related	to	impaired	
maternal care.114 Furthermore, rats that display low levels of ma‐
ternal	 care	 exhibit	 lower	 oxytocin	 receptor	 binding	 in	 the	 mPOA	
of the hypothalamus,115 which strengthens the importance of this 
region	with	respect	to	regulating	sensitive	maternal	care.	The	ACC	
also plays a key role in mediating appropriate responses to infant 
stimuli. In response to an infant cry, human mothers with lower de‐
pressive	symptoms	have	increased	activity	in	the	dorsal	ACC.116,117 
Perhaps	depression	 interferes	with	ACC‐related	empathy	 that	 has	
been demonstrated with human neuroimaging meta‐analyses118,119 
and parental brain studies.65,120 Furthermore, depressed mothers 
have	been	shown	to	exhibit	decreases	in	the	ACC‐dependent	rs‐FC	
compared to healthy controls.76
The present study is preliminary and has notable limitations. 
First, given that the CG mothers were not affected by OUD at all and 
F I G U R E  8   The scatter plots relating 
the 1 month postpartum (T1) to 
4 months postpartum (T2) changes in the 
periaqueductal	gray	(PAG)‐right	amygdala	
resting‐state functional connectivity 
(rs‐FC) to T1/T2 Postpartum Bonding 
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use disorder; CG, comparison group
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there was no placebo control, we could not control the influence of 
previous opioid use in confounding the effects of buprenorphine per 
se. Given the ethical and feasibility barriers to a placebo control trial 
with OUD subjects, future studies may be able to approach the pure 
effects of opioids with longitudinal research in which subjects are 
their own controls at different doses and time points. Future stud‐
ies will also require a full characterisation of participants with OUD, 
including the quantity and frequency of all prescriptions, as well as 
licit and illicit drug, using a “time‐line follow back” interview with 
calendar prompts and other memory aids to facilitate accurate re‐
call.121‐123 It will be also important to consider receptor occupancy as 
an	important	aspect	of	opioid	dosing.	Additional	consideration	will	
be required regarding the possible medical consequences of OUD, 
as well as sociodemographic and medical backgrounds, especially 
because we already know that parental stress, poverty, anxiety and 
postpartum depression affect the parental brain.80,124‐126 Indeed, 
stress response dysregulation has been established in other sub‐
stance use disorders.127‐130	 As	 noted	 in	 the	 Introduction,	 changes	
in rs‐FC must be interpreted with caution because they do not cap‐
ture the directionality of effect, and instead reflect basic associa‐
tions of brain activity at rest, which are themselves under study . 
Next, as a result of the small sample size in the samples with PBQ, 
the results with respect to testing the group difference in PBQ and 
the	 associations	 between	 the	PBQ	 subscales	 and	PAG‐dependent	
rs‐FC warrant replication in future studies. Furthermore, there are 
complex caveats around the measurement of parental thoughts and 
behaviours. In the present study, we only used the PBQ, which is 
a self‐report measure that may not capture aspects of parenting 
about which participants may be embarrassed or unaware. Future 
work would benefit from more comprehensive interviews such as 
the working model of the child interview131 and parental interview 
of thoughts and behaviours,66,132 as well as video‐based objective 
measures of parenting sensitivity, intrusiveness, interfering, forcing, 
overriding, anger/hostility and criticising of their child.133‐135 Finally, 
the translational validity of the MBN across species requires more 
ethologically valid neuroimaging paradigms connected to real‐world 
behavioural condition.
Although	preliminary,	the	present	study	probes	potential	buprenor‐
phine effects on mothers affected by OUD. BT is currently the best prac‐
tice for pregnant women suffering OUD, despite the potential adverse 
effects of any exogenous opioids on maternal behaviour. It is therefore 
important to examine whether buprenorphine treatment for OUD, as a 
partial mu‐opioid agonist and kappa‐opioid antagonist, exerts beneficial 
or harmful effects on maternal brain and behaviour during the postpar‐
tum. On the one hand, our work may have identified a brain mechanism 
for the potential benefits of buprenorphine treatment with respect to 
reversing abnormality of maternal brain function and behaviour: the ini‐
tial	group	differences	in	PAG‐dependent	resting‐state	functional	con‐
nectivity had dissipated by 4 months postpartum, perhaps representing 
postpartum adjustments in this sample of mothers with healthy infants 
who were receiving ongoing medical care. On the other hand, our work 
may	have	identified	a	potential	link	between	excessive	PAG‐hypothal‐
amus functional connectivity and bonding impairments, for which the 
effects of buprenorphine remain undetermined. In the future, this work 
may be combined with brain models of other conditions that interfere 
with parenting, such as parental stress, poverty, anxiety and postpar‐
tum depression,80,124‐126 as well as potential brain mechanisms at work 
in parenting interventions,136 to inform and optimise comprehensive 
interventions for BT mothers and fathers and identify the potential 
links between parental brain function and child outcomes.137 In sum, 
our	preliminary	work	calls	for	more	attention	to	PAG‐dependent	func‐
tional connectivity in the MBN as a possible brain mechanism for better 
assessing opioid‐sensitive parental brain functions in the context of par‐
enting behaviours and parent‐child bonding.
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